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Background: The Pubchem Database is a large-scale resource for chemical information, containing millions of
chemical compound activities derived by high-throughput screening (HTS). The ability to extract characteristic
substructures from such enormous amounts of data is steadily growing in importance. Compounds with shared
basic active structures (BASs) exhibiting G-protein coupled receptor (GPCR) activity and repeated dose toxicity have
been mined from small datasets. However, the mining process employed was not applicable to large datasets
owing to a large imbalance between the numbers of active and inactive compounds. In most datasets, one active
compound will appear for every 1000 inactive compounds. Most mining techniques work well only when these
numbers are similar.
Results: This difficulty was overcome by sampling an equal number of active and inactive compounds. The
sampling process was repeated to maintain the structural diversity of the inactive compounds. An interactive KNIME
workflow that enabled effective sampling and data cleaning processes was created. The application of the cascade
model and subsequent structural refinement yielded the BAS candidates. Repeated sampling increased the ratio of
active compounds containing these substructures. Three samplings were deemed adequate to identify all of the
meaningful BASs. BASs expressing similar structures were grouped to give the final set of BASs. This method was
applied to HIV integrase and protease inhibitor activities in the MDL Drug Data Report (MDDR) database and to
procaspase-3 activators in the PubChem BioAssay database, yielding 14, 12, and 18 BASs, respectively.
Conclusions: The proposed mining scheme successfully extracted meaningful substructures from large datasets of
chemical structures. The resulting BASs were deemed reasonable by an experienced medicinal chemist. The mining
itself requires about 3 days to extract BASs with a given physiological activity. Thus, the method described herein is
an effective way to analyze large HTS databases.Background
The extraction of compounds with characteristic sub-
structures and a certain physiological activity from large
chemical databases is an important step in determining
structure-activity relationships. The concept of basic ac-
tive structures (BASs) has been discussed previously [1].
A BAS is a substructure that is generally indicative of a
certain biological activity. A set of BASs is expected to
cover most of the active compounds in a given assay
dataset. BASs have already been extracted for G-protein
coupled receptor (GPCR)-related activity and repeated
dose toxicity, and the results have been disclosed on the
BASiC website [2].* Correspondence: okada@dm-lab.info
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reproduction in any medium, provided the orPharmaceutical companies produce in-house datasets
via high-throughput screening (HTS), and these datasets
can contain hundreds of thousands of compounds. The
PubChem BioAssay Project releases large-scale screening
databases for public use [3]. While some research has fo-
cused on predicting biological activity based on these
data, the results have not provided insight on character-
istic structures [4,5]. Rough set and activity landscape
methods have provided useful suggestions as to the ac-
tive substructure, but the number of molecules in the
datasets was limited [6,7].
The extraction of BASs from these datasets provides a
means of recognizing a pharmacophore with a target ac-
tivity. However, the previous mining technique employed
by the authors, which was based on a cascade model,
was not applicable to large HTS datasets. The numberral Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Takada et al. Journal of Cheminformatics 2013, 5:15 Page 2 of 12
http://www.jcheminf.com/content/5/1/15of inactive compounds in such databases is usually 1000
times that of active compounds. The magnitude of this
imbalance prohibits the extraction of characteristic sub-
structures of active compounds. This difficulty is not
limited to the cascade model but is also commonly en-
countered in most data-mining methods. The current
report introduces a sampling technique that can be used
to overcome the problems associated with unbalanced
data. The technique uses all of the active compounds
and an equal number of randomly sampled inactive
compounds. Repeating the sampling process yields sev-
eral sets of similar BASs while avoiding sampling biases.
The overall mining process was demonstrated by
extracting BASs exhibiting HIV integrase inhibitor activ-
ity from the MDL Drug Data Report (MDDR) database.
All compounds without a reference to this activity were
assumed to be inactive. The tedious task of data prepro-
cessing was reduced by the development of a KNIME
workflow. The strategy was also applied to extract com-
pounds with HIV protease activity from the MDDR
database and compounds showing procaspase-3 activa-
tor activity from the PubChem BioAssay database. All
of the developed software environments have been
disclosed free of charge on the Internet.Experimental
Workflow for pre-processing
Simple handling processes are necessary to eliminate or
minimize the most tedious tasks involved in repeated
sampling, data cleaning, and mining. The following sec-
tion describes a KNIME (version 2.4.0) workflow that
was developed to pre-process compound data [8]. The
MDDR database (version 2003.1) was used as the data
source targeting HIV integrase inhibitors [9]. The
MDDR database contains more than 130,000 records, of
which only 153 compounds show the desired activity.
All other compounds were assumed to be inactive.Workflow
There are five steps in the data sampling and cleaning
processes, shown as a KNIME workflow in Figure 1.
Pre-processing steps are expressed as meta nodes, each
of which contains several sub-workflows.I II
Figure 1 Overview of the KNIME workflow.Data sampling
Meta node I contains the sampling workflow detailed in
Figure 2. First, compounds with an unknown class label
are filtered out in step I-A. Row splitter node I-B is used
to divide the active and inactive compounds. Sampling is
done in I-C and selects an equal number of inactive and
active compounds. Subsequent steps assign new IDs to
the concatenated table.
Desalt
Meta node II desalts the sampled compounds. As shown
in Figure 3, meta node II-A performs the actual
desalting, and II-E checks the result.
An input molecule that is converted to a molecule ob-
ject of RDKit in node II-A-1 is transformed to canonical
SMILES in node II-A-2. A Java program was developed
to recognize and remove salts to be used in node II-A-3,
and the results were converted to SMILES.
The desalt program failed when the salt was larger
than the drug itself. In these cases, the meta node II-E
in Figure 3 checks the results manually.
The first node II-E-1 is an R node (II-E-1), in which
the R script provides an interactive editing of the
SMILES string. The user interface for this step is shown
in Figure 4. Candidate structures of desalted compounds
can be seen at the lower right. The SMILES string in
the lower left of Figure 4 is edited interactively if an
erroneously desalted structure is encountered. Modified
SMILES strings are then classified, and row IDs are at-
tached in steps II-E-2, -3, and -4. In this way, interactive
editing transforms the traditionally tedious desalting into
an efficient process.
Normalizing charge and tautomers
These processes use the same workflow as that shown at
the top of Figure 3. Normalizing charge and tautomers
use the new meta nodes III-A and IV-A depicted at the
bottom of Figure 3, respectively. A Python script was de-
veloped to normalize charges in node III-A-1 of Figure 3.
The following steps change the molecular format from
normalized SMILES to RDKit Canon Smiles.
OpenEye’s QuacPac [10] was used to normalize tauto-
mers in the External Tool (Labs) Node IV-A-1 in
Figure 3. The following nodes serve to change the mo-
lecular format and allow interactive validation of theIII IV V
I-A                   I-B                      I-C                    I-D               I-E                I-F
Figure 2 Data sampling workflow.
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used in the desalt step.Removing duplicate structures
The last task in the pre-processing is the removal of du-
plicate compounds resulting from desalting and normal-
izing tautomers. The details of meta node V are shown
in Figure 5, where duplicate compounds are judged
using canonical SMILES and depicted on the R edit con-
sole of the V-E node (the same as node II-E). Here, com-
pounds to be removed are selected; the others are
passed on to the next step.II-A II-B
II-C
Figure 3 Desalt workflow.Methods
The mining process was demonstrated using HIV
integrase inhibitor as an example BAS activity. Three
sample datasets were selected using the pre-processing
technique described in the previous section. The details
of the method can be found in Reference [1].
Fragments, rules, and structural refinement
BAS mining begins by the generation of linear fragments
from the compound structures, each consisting of two
terminal atoms and the shortest connecting path be-
tween them. In total, 192,580 fragments were generated
from the three datasets. Of these, 900 fragments with aII-F
II-E
II-D





Figure 5 Workflow for removing duplicate compounds.
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Precondition: N3H=y Main: C4H-c3:::c3H:c3H=y
Target: class Transition: 0.615 0.385 ==> 0.156 0.844 ( n y )

















Figure 6 A sample rule generated by the cascade model.
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The cascade model was then applied to discriminate ac-
tive from inactive compounds using the linear fragments
as descriptors. A brief introduction of the cascade model
is provided in Additional file 1. A new implementation
of the cascade model was used to generate rules using
the arules package. This implementation provided rules
defining conditions that are limited to existing frag-
ments. That is, rules implying that some fragment does
not exist were excluded. This restriction allows a wider
search space. An example rule is shown in Figure 6.
This rule denotes that there are 135 compounds that
meet the condition N3H=y (the existence of an amino
group with at least one hydrogen atom) with an in-
active/active compound ratio of 0.615/0.385. Further
applying the main condition C4H-c3:::c3H:c3H=y (the
existence of an aromatic ring as shown at the bottom
right in Figure 6 – this includes parts of a ring or a set
of fused rings) yields 32 compounds, and the ratio
changes to 0.156/0.844. The last BSS denotes the
strength of the rule, and its definition is given below.
Three sets of rules are obtained from three samplings
using the parameters eclat_minsup = 0.1, Threshold
_BSS=0.1. The total number of rules was 444. Inspection
of all of the rules is time-consuming and tedious. There-
fore, rules were selected using the priority measure as
follows.Figure 7 An example of structural refinement.priority ¼ Novelty•BSS
Novelty ¼ #New Covered Compounds by the Rule
#Covered Compounds by the Rule
0 ≤ Novelty ≤ 1ð Þ


















nA: #Covered Compounds after the application of the
main condition
nB: #Covered Compounds before the application of
the main condition
Subscripts P and N denote positive and negative
classes.
Step 1: Calculate the priority of all rules.
Step 2: Select the highest score rule.
Step 3: Repeat step 1 and step 2 among the unselected
rules until priority is 0.
Here, the priority is defined as the product of Novelty










SUPPORT: y/n = 38/8    SUPPORT: y/n = 34/2     SUPPORT: y/n = 33/1
BSS: 4.891                    BSS: 7.111                       BSS: 7.529
Unified BAS-A
BAS-A BAS-A’ BAS-A” 
Figure 8 A unification example of BAS candidates.
Figure 9 An example of subBAS extraction.
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selected rules. BSS (Between groups sum of squares) is
the strength of a rule, and its value is higher when the
number of covered compounds selected by the main
condition is large and when the changes in the positive/
negative ratio are large. Repetition of this rule selection
scheme resulted in 55 rules being refined in the next
step.
Structural refinement explores substructures and
identifies features that discriminate active compounds
from inactive compounds. An example of the refine-
ment process is shown in Figure 7. In the example,
the seed fragment HO-c:c is given by the main condi-
tion of a given rule. Here, the number of covered
compounds was 31 (27 actives and 4 inactives) with
an associated BSS value of 4.266. The refinement
algorithm then re-evaluates the substructure with
all possible bonds and atom pairs at all positions.
The substructure with the maximum BSS value is
employed in the next step. Step 1 in Figure 7 shows
the resulting substructure HO-c:c:c. The same process
is repeated until all subsequent attachments decrease
the BSS value. A catechol substructure was obtained
at step 4 in this example. A user with no chemical
foreknowledge mechanically refined the resulting frag-
ments in the rules to obtain BAS candidates using
this refinement system. No chemical knowledge was
applied to arrive at these candidates.
Unification of BAS candidates with similar structures
Some candidates may seem trivial, such as a benzene





















































































































Figure 10 Covering ratios and number of BASs for the sampled datasets. Sampling sets are in the ascending order of covering ratios.
Figure 11 Structures of 14 BASs obtained for HIV integrase inhibitor. The numbers in parentheses show the number of active compounds
covered by the associated BAS.
Takada et al. Journal of Cheminformatics 2013, 5:15 Page 7 of 12
http://www.jcheminf.com/content/5/1/15
Takada et al. Journal of Cheminformatics 2013, 5:15 Page 8 of 12
http://www.jcheminf.com/content/5/1/15be structurally similar and need to be unified. The selec-
tion and unification of BAS candidates are performed
manually. Figure 8 shows an example of BAS unification
of three BAS candidates. Usually, candidate structures
covering the maximum number of active compounds
were employed. In the given example, all active com-
pounds of BAS-A’ and BAS-A” are contained in those of
BAS-A. Therefore, BAS-A was identified as the unified
BAS. If the user is an experienced chemist, the candidate
expressions can be edited to yield a new BAS. A means






















Figure 12 The four compounds not covered by BASs in Figure 11.Finding subBASs
A larger substructure that is shared by a group of com-
pounds can sometimes be identified from the covered
compounds of a BAS. Such a substructure is a subBAS
and is often chemically interesting. Therefore, subBASs
are also registered in the knowledge base. Figure 9 shows
two subBASs, BAS-A-1 and -A-2, that were identified
from the covered compounds of BAS-A. The inspection
of compound structures often requires chemical know-
ledge and understanding. The covered compounds of







































































































Figure 14 Structures of 12 BASs for HIV protease inhibitor. The numbers in parentheses show the number of active compounds covered by
the associated BAS.
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The number of samplings is critical to the success of the
proposed method. Too few samplings may affect the di-
versity of inactive compounds, resulting in the wrong
BAS structure. Too many samplings are time consum-
ing. The cover ratio of active compounds is used to es-
timate the necessary number of samplings, since
identified BASs should cover the majority of active
compounds.
Cover ratios were examined during inactive sampling
of three datasets: HIV integrase inhibitors, HIV protease
inhibitors, and procaspase-3 activators. BASs were ex-
tracted from each sample dataset. The results are shown
in Figure 10.
The light and dark blue bars in Figure 10 show the
numbers of BASs and their cover ratios obtained from
each sample dataset, respectively. Between 4 and 7 BASs
were obtained, covering 65% to 88% of the active com-
pounds in the case of HIV integrase. Thus, as expected,
the BASs mined from a single sampling often fail to
cover most of the active compounds. Conversely, the cu-
mulative cover ratio, shown by the red line, reached its
maximum values after three samplings in almost all
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Figure 15 Structures of 18 BASs obtained for procaspase-3 activators
covered by the associated BAS.three samplings does not change, even after changing
the sampling order of the three activities. Therefore, the
estimated required number of samplings was three.
The number of final BASs obtained from the first
three samplings yielded 9 BASs in the case of HIV
integrase, as will be discussed in the next section. In-
spection of BAS structures obtained from the 4th and
the 5th samplings has shown that all of these BASs are
contained in the final BAS sets. This was also observed
with the protease and procaspase-3 activities. Therefore,
three samplings were deemed sufficient to yield a stable
set of BASs covering most of the active compounds.Results and discussion
HIV integrase inhibitor mining results
The cascade model was applied to three sample datasets
as discussed in the previous section. Refinement of
the 55 selected rules and subsequent BAS unification
resulted in the nine BASs (A-1 to E) shown in Figure 11.
Unification of similar BASs and the discarding of trivial
substructures were performed without a priori chemical
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. The numbers in parentheses show the number of active compounds
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teristic substructures if their covered compounds are too
few. The refinement system may still overlook meaning-
ful BAS candidates. An experienced chemist evaluated
23 uncovered structures. While this resulted in six
additional interesting substructures, one of them also
appeared frequently among the inactive compounds.
Finally, five new BASs were added, shown by F, G, H, I,
and J in Figure 11, where BAS J is a generalization of D-1.
These BASs covered 19 new compounds with only 4 of
the 153 active compounds left uncovered. Structures of
the four uncovered compounds are shown in Figure 12.
A question arises as to which components of a pharma-
ceutical substructure are expressed by the obtained BASs.
A review paper of HIV integrase inhibitors showed seven
typical active compounds [11]. The BAS components are
given in Figure 13.
The red dashed lines in Figure 13 indicate BASs selected
without a priori chemical knowledge. The blue dotted
lines indicate BASs mined by an experienced chemist.
This result illustrates the importance of BASs in real
pharmaceuticals.
Applications to other biological activities
HIV protease inhibitor
The next target of active compound mining was HIV
protease inhibitor in the MDDR database. In total, 758
active compounds were identified, and 394 rules were
obtained from three sampling datasets, each of which
contained an equal number of inactive and active com-
pounds. The rule priority criteria narrowed these to 65
rules, and subsequent structure refinement and unifica-
tion resulted in the seven BASs (A to G) depicted in
Figure 14. These BASs covered 78.3% of the active com-
pounds. This ratio is lower than that obtained for HIV
integrase inhibitor. An experienced chemist surveyed the
structures of the 164 remaining active compounds and
identified five additional BASs shown by H, I, J, K, and L
in Figure 14. These covered 61 new compounds, leaving
103 uncovered compounds with miscellaneous structures.
Procaspase-3 activators in the PubChem BioAssay
database
The last target was procaspase-3 activators in the
PubChem BioAssay database (AID: 463141). There are
326,136 compounds in the database, of which only 350
exhibit the desired activity. In total, 459 rules were
obtained from three sampling datasets, of which 86 rules
were selected by rule priority. Further refinement and
unification resulted in the 13 BASs (A to M) shown in
Figure 15. These BASs supported 66.3% of the active
compounds. This low coverage is likely the result of the
structural diversity of the compound library. An experi-
enced chemist surveyed the structures of 118 of theremaining active compounds and identified five add-
itional BASs shown by N, O, P, Q, and R in Figure 15,
which covered additional 18 active compounds.
Conclusions
BASs of three pharmacological activities were success-
fully mined from large-scale databases, including real
HTS data in the PubChem BioAssay database. Most
BASs could be mined without a priori chemical know-
ledge, and the time required to perform the mining for
one activity was about 3 days. All of the software devel-
oped is open to the public and is available at the BASiC
website. The obtained BASs were deemed meaningful
substructures from the viewpoint of a medicinal chemist.
Thus, BAS mining was shown to be a useful method for
understanding the characteristics of active structures.
Currently, the bottleneck of this mining process is the
unification of similar BASs, which requires a manual
comparison of about 100 candidate BAS structures. Fu-
ture developments to the current process will therefore
include an automatic method to identify similar candi-
date BASs and to construct new, refined BASs. Software
development to mine BASs with fewer covered com-
pounds is also in progress.
Additional files
Additional file 1: Contains a brief introduction to the cascade model.
Additional file 2: Illustrates how BAS candidates were converted to
a unified BAS.
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